Atossa Therapeutics Inc (NASDAQ: ATOS) kicked off on Friday, down -8.82% from the previous trading day, before settling in for the closing price of $0.9. Over the past 52 weeks, ATOS has traded in a range of $0.55-$1.29.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 36.92%. While this was happening, its average annual earnings per share was recorded -25.00%. With a float of $129.12 million, this company’s outstanding shares have now reached $129.17 million.
Atossa Therapeutics Inc (ATOS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Atossa Therapeutics Inc is 0.04%, while institutional ownership is 19.43%. The most recent insider transaction that took place on May 21 ’25, was worth 9,887. In this transaction President & CEO of this company bought 11,239 shares at a rate of $0.88, taking the stock ownership to the 13,898 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Director bought 10,000 for $0.70, making the entire transaction worth $7,000. This insider now owns 10,257 shares in total.
Atossa Therapeutics Inc (ATOS) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.05 earnings per share (EPS), higher than consensus estimate (set at -0.06) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -25.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -17.57% during the next five years compared to 36.92% growth over the previous five years of trading.
Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators
Take a look at Atossa Therapeutics Inc’s (ATOS) current performance indicators. Last quarter, stock had a quick ratio of 6.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.23, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.29 in one year’s time.
Technical Analysis of Atossa Therapeutics Inc (ATOS)
The latest stats from [Atossa Therapeutics Inc, ATOS] show that its last 5-days average volume of 1.87 million was superior to 0.87 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 69.09%.
During the past 100 days, Atossa Therapeutics Inc’s (ATOS) raw stochastic average was set at 23.17%, which indicates a significant decrease from 45.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0535 in the past 14 days, which was higher than the 0.0484 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8782, while its 200-day Moving Average is $0.8191. Now, the first resistance to watch is $0.8859. This is followed by the second major resistance level at $0.9469. The third major resistance level sits at $0.9797. If the price goes on to break the first support level at $0.7921, it is likely to go to the next support level at $0.7593. The third support level lies at $0.6983 if the price breaches the second support level.
Atossa Therapeutics Inc (NASDAQ: ATOS) Key Stats
The company with the Market Capitalisation of 106.57 million has total of 129,171K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -25,500 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -8,690 K.
